Exelixis Inc (EXEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXEL | JAZZ | QGEN | ||
| Company | Exelixis Inc | Jazz Pharma Plc | Qiagen N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 42.50 | 186.05 | 43.69 | ||
| High | 42.67 | 188.62 | 43.69 | ||
| Low | 41.38 | 184.30 | 42.45 | ||
| Latest | 41.58 | 186.96 | 43.08 | ||
| Change | -0.79 | +1.56 | -0.25 | ||
| % Change | -1.86% | +0.84% | -0.58% | ||
| Volume | 1,221,828 | 485,284 | 1,526,880 | ||
| 20-Day Average Volume | 3,191,803 | 1,099,243 | 1,944,776 | ||
| Previous Close | 42.37 | 185.40 | 43.33 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 43.07 | 178.52 | 48.12 | ||
| 20-Day Raw Stochastic | 30.84% | 71.76% | 7.25% | ||
| 20-Day Relative Strength | 44.50 | 61.56 | 30.07 | ||
| Weighted Alpha | +6.46 | +46.32 | -5.97 | ||
| Today's Opinion | 8% Buy | 100% Buy | 56% Sell | ||
| Previous Opinion | 24% Buy | 100% Buy | 56% Sell | ||
| Last Month's Opinion | 72% Buy | 40% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.14% since 03/03/26 | +0.53% since 03/03/26 | -9.39% since 03/03/26 | ||
| Low | 40.24 on 03/06/26 | 176.67 on 03/06/26 | 42.47 on 03/10/26 | ||
| High | 42.63 on 03/10/26 | 190.67 on 03/04/26 | 47.98 on 03/04/26 | ||
| 1-Month | |||||
| %Chg | -3.19% since 02/10/26 | +13.30% since 02/10/26 | -15.48% since 02/10/26 | ||
| Low | 39.71 on 03/02/26 | 161.38 on 02/11/26 | 42.47 on 03/10/26 | ||
| High | 45.87 on 02/25/26 | 198.00 on 02/26/26 | 52.20 on 02/13/26 | ||
| 3-Month | |||||
| %Chg | +1.31% since 12/10/25 | +13.75% since 12/10/25 | -10.17% since 12/10/25 | ||
| Low | 39.71 on 03/02/26 | 156.95 on 01/08/26 | 42.47 on 03/10/26 | ||
| High | 47.24 on 12/23/25 | 198.00 on 02/26/26 | 57.81 on 01/20/26 | ||
| 6-Month | |||||
| %Chg | +10.37% since 09/10/25 | +47.88% since 09/10/25 | -10.85% since 09/10/25 | ||
| Low | 33.76 on 10/20/25 | 123.88 on 09/15/25 | 42.47 on 03/10/26 | ||
| High | 47.24 on 12/23/25 | 198.00 on 02/26/26 | 57.81 on 01/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,003,871 | 11,413,224 | 9,150,256 | ||
| Shares Outstanding, K | 259,709 | 61,560 | 211,176 | ||
| Annual Sales | 2,320,130,000 | 4,267,590,000 | 2,090,000,000 | ||
| Annual Net Income | 782,570,000 | -356,150,000 | 424,880,000 | ||
| Last Quarter Sales | 598,660,000 | 1,197,930,000 | 540,420,000 | ||
| Last Quarter Net Income | 244,530,000 | 203,450,000 | 107,830,000 | ||
| 60-Month Beta | 0.41 | 0.22 | 0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.94 on 02/10/26 | 6.64 on 02/24/26 | 0.62 on 02/04/26 | ||
| Latest Earnings Date | 05/12/26 | 05/05/26 | 05/06/26 | ||
| Most Recent Dividend | N/A | N/A | 0.250 on 07/02/25 | ||
| Next Ex-Dividends Date | N/A | N/A | 07/02/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 15.22 | 42.53 | 18.02 | ||